The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Neuroinflammation and Oxidative Stress in Diabetic Neuropathy: Futuristic Strategies Based on These Targets
Open accessAbstract
In Diabetes, the chronic hyperglycemia and associated complications affecting peripheral nerves are one of the most commonly occurring microvascular complications with an overall prevalence of 50–60%. Among the vascular complications of diabetes, diabetic neuropathy is the most painful and disabling, fatal complication affecting the quality of life in patients. Several theories of etiologies surfaced down the lane, amongst which the oxidative stress mediated damage in neurons and surrounding glial cell has gained attention as one of the vital mechanisms in the pathogenesis of neuropathy. Mitochondria induced ROS and other oxidants are responsible for altering the balance between oxidants and innate antioxidant defence of the body. Oxidative-nitrosative stress not only activates the major pathways namely, polyol pathway flux, advanced glycation end products formation, activation of protein kinase C, and overactivity of the hexosamine pathway, but also initiates and amplifies neuroinflammation. The cross talk between oxidative stress and inflammation is due to the activation of NF-κ B and AP-1 and inhibition of Nrf2, peroxynitrite mediate endothelial dysfunction, altered NO levels, and macrophage migration. These all culminate in the production of proinflammatory cytokines which are responsible for nerve tissue damage and debilitating neuropathies. This review focuses on the relationship between oxidative stress and neuroinflammation in the development and progression of diabetic neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
The neuropathic pain triad: neurons, immune cells and glia
Scholz, J., & Woolf, C. J. (2007) · Nature Neuroscience · doi:10.1038/nn1992 · Cited by 1,732
Crosslinking of recycled polyethylene by gamma and electron beam irradiation
Adem, E., Avalos-Borja, M., Carrillo, D., Vazquez, M., Sanchez, E., Carreon, M. P., & Burillo, G. (1998) · Radiation Physics and Chemistry · doi:10.1016/s0969-806x(98)00134-0 · Cited by 1,450
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
Du, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengellér, Z., Szabó, C., & Brownlee, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18127 · Cited by 832
Sima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Oxidative Stress and Cell Signalling
Poli, G., Leonarduzzi, G., Biasi, F., & Chiarpotto, E. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365323 · Cited by 722
Liu, G.-H., Qu, J., & Shen, X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.002 · Cited by 697
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639 · cited 2×
“Additionally, neuroinflammation leads to nerve damage due to apoptosis induced by MAPK signalling [44].”
BackgroundContribution of Polyol Pathway to Diabetes-Induced Oxidative Stress
Chung, S. S. M., Ho, E. C. M., Lam, K. S. L., & Chung, S. K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077408.15865.06 · Cited by 609
When NRF2 Talks, Who's Listening?
Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S., & Kensler, T. W. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3216 · Cited by 595
PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells
VALLE, I., ALVAREZBARRIENTOS, A., ARZA, E., LAMAS, S., & MONSALVE, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.026 · Cited by 556
Multiple pathways of peroxynitrite cytotoxicity
Szabó, C. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00507-6 · Cited by 506
Malik, R. A., Kallinikos, P., Abbott, C. A., van Schie, C. H. M., Morgan, P., Efron, N., & Boulton, A. J. M. (2003) · Diabetologia · doi:10.1007/s00125-003-1086-8 · Cited by 505
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Hasche, H., Lobisch, M., Schütte, K., Kerum, G., & Malessa, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1296 · Cited by 432
Kolm-Litty, V, Sauer, U., Nerlich, A., Lehmann, R., & Schleicher, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119875 · Cited by 430
Ganesh Yerra, V., Negi, G., Sharma, S. S., & Kumar, A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.005 · Cited by 412
Self-citationDiabetic peripheral neuropathy: Current perspective and future directions
Singh, R., Kishore, L., & Kaur, N. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.12.005 · Cited by 400
Tan, Y., Ichikawa, T., Li, J., Si, Q., Yang, H., Chen, X., Goldblatt, C. S., Meyer, C. J., Li, X., Cai, L., et al. (2011) · Diabetes · doi:10.2337/db10-1164 · Cited by 392
Diabetic Neuropathy: An intensive review
Duby, J. J., Campbell, R. K., Setter, S. M., White, J. R., & Rasmussen, K. A. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.2.160 · Cited by 382
Protection of Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic Cardiomyopathy
Shen, X., Zheng, S., Metreveli, N. S., & Epstein, P. N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1039 · Cited by 378
Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080362 · Cited by 332
Pacher, P., Obrosova, I., Mabley, J., & Szabo, C. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363207 · Cited by 330
Negi, G., Kumar, A., & Sharma, S. S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00821.x · Cited by 314
Self-citationA role for mitogen‐activated protein kinases in the etiology of diabetic neuropathy
PURVES, T., MIDDLEMAS, A., AGTHONG, S., JUDE, E. B., BOULTON, A. J. M., FERNYHOUGH, P., & TOMLINSON, D. R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0253hyp · Cited by 274
Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction.
Srinivasan, S., Stevens, M., & Wiley, J. W. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1932 · Cited by 267
Role of Advanced Glycation End Products and Their Receptors in Development of Diabetic Neuropathy
WADA, R., & YAGIHASHI, S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.067 · Cited by 263
The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets
Myers, R. R., Campana, W. M., & Shubayev, V. I. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03637-8 · Cited by 255
Sima, A. A. F., Calvani, M., Mehra, M., Amato, A., & for the Acetyl-l-Carnitine Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.1.89 · Cited by 234
Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Oates, P. (2008) · Current Drug Targets · doi:10.2174/138945008783431781 · Cited by 231
Obrosova, I. G., Drel, V. R., Pacher, P., Ilnytska, O., Wang, Z. Q., Stevens, M. J., & Yorek, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3435 · Cited by 231
Vinik, A. I., & Mehrabyan, A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.009 · Cited by 229
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy
Wang, X.-M., Lehky, T. J., Brell, J. M., & Dorsey, S. G. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.027 · Cited by 220
Chen, Y.-Q., Su, M., Walia, R. R., Hao, Q., Covington, J. W., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8225 · Cited by 217
Prevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ
Chacko, B. K., Reily, C., Srivastava, A., Johnson, M. S., Ye, Y., Ulasova, E., Agarwal, A., Zinn, K. R., Murphy, M. P., Kalyanaraman, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100308 · Cited by 204
Inhibition of Endothelial Nitric Oxide Synthase Activity by Protein Kinase C
Hirata, K.-I., Kuroda, R., Sakoda, T., Katayama, M., Inoue, N., Suematsu, M., Kawashima, S., & Yokoyama, M. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.180 · Cited by 188
Endoplasmic Reticulum Stress Plays a Key Role in the Pathogenesis of Diabetic Peripheral Neuropathy
Lupachyk, S., Watcho, P., Stavniichuk, R., Shevalye, H., & Obrosova, I. G. (2013) · Diabetes · doi:10.2337/db12-0716 · Cited by 188
New perspectives on the management of diabetic peripheral neuropathic pain
Jensen, T. S., Backonja, M.-M., Jiménez, S. H., Tesfaye, S., Valensi, P., & Ziegler, D. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.013 · Cited by 187
Kumar, A., & Sharma, S. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.014 · Cited by 183
Self-citationNegi, G., Kumar, A., & S. Sharma, S. (2011) · Current Neurovascular Research · doi:10.2174/156720211798120972 · Cited by 183
Self-citationPro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Cameron, N., & Cotter, M. (2008) · Current Drug Targets · doi:10.2174/138945008783431718 · Cited by 179
Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes
Cameron, N. E., & Cotter, M. A. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00043-1 · Cited by 174
Mitochondria-targeted antioxidants as therapies.
Smith, R. A. J., & Murphy, M. P. (2011) · PubMed · Cited by 173
Lee, H. B., Yu, M. R., Song, J. S., & Ha, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00491.x · Cited by 168
Šoškić, S., Dobutović, B. D., Sudar-Milovanovic, E. M., Obradovic, M. M., Nikolić, D., Djordjevic, J. D., Radak, D. J., Mikhailidis, D. P., & Isenović, E. R. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010153 · Cited by 158
Obrosova, I. G., Mabley, J. G., Zsengellér, Z. K., Charniauskaya, T., Abatan, O. I., Groves, J. T., & Szabó, C. (2004) · The FASEB Journal · doi:10.1096/fj.04-1913fje · Cited by 157
Vincent, A. M., Edwards, J. L., McLean, L. L., Hong, Y., Cerri, F., Lopez, I., Quattrini, A., & Feldman, E. L. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0697-7 · Cited by 152
Painful diabetic neuropathy: treatment and future aspects
Ziegler, D. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.817 · Cited by 149
Alpha-Lipoic Acid and Diabetic Neuropathy
Vallianou, N. G., Evangelopoulos, A. A., & Koutalas, P. (2009) · The Review of Diabetic Studies · doi:10.1900/rds.2009.6.230 · Cited by 145
Beneficial effect of TNF-α inhibition on diabetic peripheral neuropathy
Shi, X., Chen, Y., Nadeem, L., & Xu, G. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-69 · Cited by 141
Kellogg, A. P., Wiggin, T. D., Larkin, D. D., Hayes, J. M., Stevens, M. J., & Pop‐Busui, R. (2007) · Diabetes · doi:10.2337/db07-0740 · Cited by 140
The role of glycation in the pathogenesis of diabetic polyneuropathy
King, R. H. M. (2001) · Molecular Pathology · doi:10.1136/mp.54.6.400 · Cited by 136
Cameron, N. E., Cotter, M. A., Jack, A. M., Basso, M., & Hohman, T. C. (1999) · Diabetologia · doi:10.1007/s001250051280 · Cited by 132
Bardini, G., Rotella, C. M., & Giannini, S. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.82 · Cited by 124
Kumar, A., Negi, G., & Sharma, S. S. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01402.x · Cited by 121
Self-citationKumar, A., Negi, G., & Sharma, S. S. (2012) · Biochimie · doi:10.1016/j.biochi.2012.01.023 · Cited by 116
Self-citationKamboj, S. S., Vasishta, R. K., & Sandhir, R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06435.x · Cited by 113
Pop‐Busui, R., Marinescu, V., Huysen, C. V., Li, F. Y., Sullivan, K., Greene, D. A., Larkin, D. D., & Stevens, M. J. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2619 · Cited by 107
Skin Biopsy as a Tool to Assess Distal Small Fiber Innervation in Diabetic Neuropathy
Polydefkis, M. J., Hauer, P., Griffin, J. W., & McArthur, J. C. (2001) · Diabetes Technology & Therapeutics · doi:10.1089/152091501750219994 · Cited by 103
PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy
Choi, J., Chandrasekaran, K., Inoue, T., Anjaneyulu, M., & Russell, J. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.001 · Cited by 102
Takeuchi, M., Takino, J.-I., & Yamagishi, S. (2010) · Current Drug Targets · doi:10.2174/1389450111009011468 · Cited by 101
Tütüncü, N. B., Bayraktar, M., & Varlı, K. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1915 · Cited by 96
Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy
Fernyhough, P., Huang, T., & Verkhratsky, A. (2003) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2003.03028.x · Cited by 95
Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro
Schmid, U., Stopper, H., Heidland, A., & Schupp, N. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.860 · Cited by 89
Diabetic Peripheral Neuropathy: Should a Chaperone Accompany Our Therapeutic Approach?
Farmer, K. L., Li, C., & Dobrowsky, R. T. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005314 · Cited by 87
Negi, G., Kumar, A., Kaundal, R. K., Gulati, A., & Sharma, S. S. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.018 · Cited by 84
Self-citationPainful Diabetic Neuropathy: A Management-Centered Review
Huizinga, M. M., & Peltier, A. (2007) · Clinical Diabetes · doi:10.2337/diaclin.25.1.6 · Cited by 74
Cameron, N. E., Dines, K. C., & Cotter, M. A. (1994) · Diabetologia · doi:10.1007/bf00399794 · Cited by 69
Mitochondrial Dynamics in Peripheral Neuropathies
Sajic, M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5822 · Cited by 42
Effect of C‐Peptide on Diabetic Neuropathy in Patients with Type 1 Diabetes
Ekberg, K., & Johansson, B. (2008) · Journal of Diabetes Research · doi:10.1155/2008/457912 · Cited by 41
Redox regulation in acute and chronic inflammation
Maccarrone, M., & Brüne, B. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.65 · Cited by 25
Efficiency of superoxide anions in the inactivation of selected dehydrogenases
Rodacka, A., Serafin, E., & Puchała, M. (2010) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2010.04.001 · Cited by 18
Diagnosis of Diabetic Neuropathy
Veves, A. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_4 · Cited by 8
Cited by
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
Free radicals and their impact on health and antioxidant defenses: a review
Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I., & Lee, S. J. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02278-8 · Cited by 669
Neuropathy and Diabetic Foot Syndrome
Volmer-Thole, M., & Lobmann, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060917 · Cited by 407
Nutrients and Oxidative Stress: Friend or Foe?
Tan, B. L., Norhaizan, M. E., & Liew, W.-P.-P. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9719584 · Cited by 403
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Suryavanshi, S. V., & Kulkarni, Y. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00798 · Cited by 348
Metadata
- Authors
- Sandireddy, R., Yerra, V. G., Areti, A., Komirishetty, P., & Kumar, A.
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-10
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- OpenAlex
- W2077023300
- Cited by
- 364
- References
- 82
- FWCI
- 17.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.